fda glp-1 warning letters september 2025 news issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's crackdown on misleading September 8, 2025: FDA launches

On just the Hims Hers platform alone, nearly 80,000 individuals have shared they cannot access branded GLP-1 medications

While a number of mechanisms including vascular, myocardial, renal, and central nervous system pathways have been suggested in animal studies, these mechanistic pathways have not been sufficiently detailed in humans and it is unclear if the same pathways are operational

Youre keeping up with your GLP-1 pill or injection schedule, and you cant wait to see results in your blood sugar and weight loss

Natural Ingredients No

Silence Cravings, Feel Satisfied: Fight stubborn food urges naturally no harsh stimulants

Hims & Hers faces rising regulatory pressure on compounded GLP-1s.